NF2 and malignant mesothelioma: Amongst the various cancer indications where the Hippo pathway is deregulated, malignant mesothelioma is the primary indication selected in these clinical studies due to the high unmet medical need and the highest reported frequency of somatic mutations in NF2–Hippo, although other solid tumor indications will also be evaluated as discussed below.